Vasopressin. Other and unspecified hormone antagonists
Conditions
Interventions
Intervention 1: Intervention group patients receive Vasopressin 1% unit/minute during operation. Intervention 2: Control group patients receive placebo during operation.
Treatment - Drugs
Intervention group patients receive Vasopressin 1% unit/minute during operation.
Control group patients receive placebo during operation.
Sponsors
Tehran University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: A.S.A class 1&2, Age: 20-80, undergoing Total Hip Arthroplasty under Regional Anesthesia Exclusion criteria: Bleeding disorders, Previous Total Hip Arthroplasty
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transfusion. Timepoint: during operation. Method of measurement: Nomber of Blood package. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: After operation. Method of measurement: Labratory instrument (scale g/dL).;Platelet. Timepoint: After operation. Method of measurement: Labratory instrument.;Prothrombin time = Pt. Timepoint: After operation. Method of measurement: Labratory instrument.;Partial thromboplastin time = Ptt. Timepoint: After operation. Method of measurement: Labratory instrument.;International Normalized Ratio = INR. Timepoint: After operation. Method of measurement: Labratory instrument. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarsad Imani, Anesthesiologist, Assistant Professor
Anesthesia Group, Tehran University of Medical Sciences
Outcome results
None listed